Alique Topalian is a 2-time cancer survivor. She is now in remission and using her voice to passionately raise awareness about the unique needs of cancer patients. Her experience with childhood cancer inspired her to obtain a Master’s in Public Health and a Ph.D. in Health Promotion and Education completing her degree in 2020. Little did she know that in March of 2021 she would relapse with AML, the first person to ever relapse after 22 years. During her time in active treatment, she used every opportunity to network, participate in psychosocial programming, and educate herself on resources available to patients in all stages of treatment. Alique was selected as a 2022 recipient of the 40 Under 40 in Cancer award and was recognized as 100 Influential Women in Oncology in 2024. She is sharing her experience with The University of Cincinnati as a Research Scientist to research patient experience, oncology primary care, cancer related cognitive impairment, AYAs, and survivorship.